Preventing the next pandemic: Learning the lessons
In the first of a three part series, Ben Hargreaves looks at what the odds are of another pandemic arising in our lifetimes and what […]
COVID
Matthew’s health care tidbits: Is Covid over for the health care system?
Each week I’ve been adding a brief tidbits section to the THCB Reader, our weekly newsletter that summarizes the best of THCB that week (Sign […]
How the test-to-treat pillar of the U.S. Covid strategy is failing patients
Large swaths of the country had no test-to-treat pharmacies or health centers listed as of April 14. And the website of the largest participant, CVS, […]
Causes of Death 2015-2020: Where does COVID-19 rank?
A paper by Ahmad and Anderson in JAMA last spring examined trends in the causes of death in the US. Below are the charts in […]
Refining digital collaboration
Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to COVID, the industry had begun moving toward […]
Blood Cancer UK: Hopes for our community’s future in the time of COVID
This thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness Month, Blood Cancer UK’s Kate Keightley explains […]
Sleepless Nights For Evolutionary Biologists: A Greek Tragedy in The Making
By MIKE MAGEE In my Jesuit high school, we were offered only one science course – chemistry. I took it in my Senior year and […]
Cancer research faces uncertain post-COVID landscape
There’s a bright future ahead for cancer research in the UK, but only if the government is able to implement a clear plan for funding […]
Oncology and a year of COVID: lessons for the future
COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up opportunities to take learnings and create long-lasting […]
How hybrid virtual engagement is accelerating oncology communication
COVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement needs to move away from an overreliance […]
Why pharma shouldn’t forget about sites in a post-COVID world
The pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we must recalibrate and work with sites to […]
COVID-19 public health emergency waiver flexibilities and the path to reducing regulatory burden
In November 2020, the Department of Health and Human Services (HHS) released two requests for information (RFIs), seeking input from stakeholders on reducing regulatory burden […]
Keeping clinical trial data safe – handling cybersecurity in a risky world
The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare. However the increased complexity and involvement of […]
Inside the UK’s leading efforts to restart clinical research
A herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute for Health Research’s (NIHR) Restart Framework. Experts […]
Pfizer files tick-borne encephalitis shot with FDA
Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is […]
How to Create an Effective COVID-19 Vaccine Communication Strategy for Your Patients
COVID-19 vaccine hesitancy remains an ongoing challenge to our nation’s public health efforts. According to a just-published KFF survey, 31% of Americans report they will […]
Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone
Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion […]
Digital therapeutics: Why human psychology is key to adoption
The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise […]
ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?”
Tomorrow, Monday, November 16 at 15:00 CET (9:00 EST/6:00 PST), I will be on an ISPOR Europe Panel titled “Will COVID-19 Accelerate the Adoption of […]
COVID19: The Impact of the Early Failure to Respond
COVID19: The Impact of the Early Failure to Respond The well-documented COVID19 chapter of Abramson’s book, Proof of Conspiracy, details our early failure to respond. […]
2 billion vials. Public acceptance. The obstacles to vaccine delivery
The post 2 billion vials. Public acceptance. The obstacles to vaccine delivery appeared first on Healthy Debate.
Dealing with a Rare Eye Disease in the Midst of COVID19
Dealing with a Rare Eye Disease in the Midst of COVID19 After being diagnosed with a rare eye disease, a doctor learns the best treatment […]
Novartis’s Spartalizumab Combo Stubles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis
Novartis’s Spartalizumab Combo Fails To Meet The Primary Goal In The Melanoma Trial Novartis recently declared the results of its Phase III COMBI-I trial evaluating […]
[Podcast] How Cleveland Clinic Helps Employers Create a Safer Workplace During COVID-19
Dr. Jim Merlino, Chief Clinical Transformation Officer, Cleveland Clinic Despite having entered the US eight months ago, COVID-19 remains a topic enshrouded in confusion, conflicting […]
California School Districts Grope for Sensible Reopening Plans
School leaders in Elk Grove, California, wanted to leave as little to chance as possible. So they brought nearly 150 voices into their decision-making process, […]
Next Showdown in Congress: Protecting Workers vs. Protecting Employers in the Pandemic
Congressional leaders are squaring off over the next pandemic relief bill in a debate over whom Congress should step up to protect: front-line workers seeking […]
[Podcast] How to Adjust Your Creative Strategies In Response to the COVID-19 Pandemic?
Dana Callow, Executive Creative Director, Healthcare Success COVID-19 has been a life-changing event for us all. It’s the kind of event that has lasting effects […]
How Are Healthcare Consumers Responding to the Coronavirus Pandemic?
COVID-19: The New Normal for Healthcare Consumers A “new normal” is emerging in healthcare for both providers and patients. Healthcare industry leaders and medical marketing […]
Key learnings for the intersection between PDGM and COVID-19 (webinar)
In a world jam-packed with COVID-19 information and communications, home health centers are looking for direction. Not only are they adapting to PDGM—the most significant […]
When to Wear Gloves To Prevent COVID-19?
Gloves form an essential part of the personal protective equipment (PPE). However, unlike masks, gloves are not supposed to be worn all the time or […]
RCM support through COVID-19, PDGM, and beyond (podcast)
A conversation between Navin Gupta, Vice President, Home Care Solutions for MatrixCare and his special guest Jeremy Crow, Senior Software Executive, Information Technology Consultant, and […]
Low-income Ontarians facing partial claw back of federal assistance during COVID-19
The post Low-income Ontarians facing partial claw back of federal assistance during COVID-19 appeared first on Healthy Debate.
Vein Practice Marketing Strategies to Implement Now
Marketing Strategies to Implement Now For Your Vein Practice A Webinar Sponsored by the American Vein and Lymphatic Society COVID-19 has caused massive economic disruption […]
Telemedicine & Telehealth Emerge as Medical Marketing Opportunities During COVID
March 17, 2020, may well be remembered as the day the telemedicine revolution finally took off. Telemedicine and Telehealth‘s adoption, fast-tracked by Coronavirus/COVID, will create profound […]
COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward
COVID Healthcare Marketing Webinar COVID-19 has changed the healthcare industry quicker in the last two weeks than in the last 50 years. With medical practices […]
